Literature DB >> 29173413

Sudden Cardiac Death in Acute Coronary Syndromes.

Nikolaos Dagres1, Gerhard Hindricks2.   

Abstract

Sudden cardiac death in acute coronary syndromes mostly results from complex ventricular arrhythmias. Although the incidence has fallen with contemporary management, they still pose a threat for many patients. Treatment consists of immediate termination by electrical cardioversion and prompt coronary revascularization for relief of ischemia. Beta-blockers administered prophylactically have a protective effect. For recurrent episodes, pharmacologic treatment consists of beta-blockers and amiodarone, or, in nonresponsive patients, lidocaine. Other antiarrhythmic drugs play only a marginal role. Catheter ablation performed in qualified centers can be effective in recurrent episodes of ventricular tachycardia or ventricular fibrillation triggered by premature ventricular contractions.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute coronary syndrome; Sudden cardiac death; Ventricular fibrillation

Mesh:

Year:  2017        PMID: 29173413     DOI: 10.1016/j.ccep.2017.08.009

Source DB:  PubMed          Journal:  Card Electrophysiol Clin        ISSN: 1877-9182


  3 in total

1.  [A new method for establishing a ventricular fibrillation model by TCEI in Tibetan miniature pig].

Authors:  Guodong Liang; Rugang Zheng; Hongjian Jian; Minhai Zhang; Huiqiong Yuan; Jiemin Hong; Gang Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-11-30

2.  Amiodarone Treatment in the Early Phase of Acute Myocardial Infarction Protects Against Ventricular Fibrillation in a Porcine Model.

Authors:  Stefan M Sattler; Anniek F Lubberding; Lasse Skibsbye; Reza Jabbari; Reza Wakili; Thomas Jespersen; Jacob Tfelt-Hansen
Journal:  J Cardiovasc Transl Res       Date:  2019-01-07       Impact factor: 4.132

3.  High arrhythmic risk in antero-septal acute myocardial ischemia is explained by increased transmural reentry occurrence.

Authors:  Hector Martinez-Navarro; Ana Mincholé; Alfonso Bueno-Orovio; Blanca Rodriguez
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.